BioSpace News Archive

According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.

CalciMedica Inc. announced the appointment of Robert N. Wilson, a former vice chairman of the Johnson & Johnson board, to the Company’s board of directors as co-chairman with current board chairman, Robert McNeil, Ph.D.

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO and Dan Dischner, Vice President of Corporate Communications and Human Resources will be presenting at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 4:00 p.m. Eastern Time.

Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), today announced the closing of an underwritten public offering of 19,475,806 shares of its common stock at a public offering price of $31.00 per share.

ATW Tech Inc. (TSX-V: ATW) (“ATW”or the “Corporation”) wishes to provide an update on the Press Release issued April 29, 2020 relating to the COVID-19 pandemic as it affects the Corporation and the status of the filing of its annual financial statements and accompanying management’s discussion and analysis, and related CEO and CFO certifications, for the financial year ended December 31, 2019 (the “Annual Filings”),

Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering

Perrigo Company plc (NYSE; TASE: PRGO) today announced that President and CEO Murray S. Kessler will present further details on the Company’s consumer growth strategy along with a general update on the business at the 20th Annual Oppenheimer Consumer Growth and E-Commerce Virtual Conference at 2:00 PM EDT

Attivo Networks®, an award-winning leader in deception for cybersecurity threat detection, today announced its participation with SINC and MIT Sloan on a research report entitled “The Cybersecurity Landscape: Challenges and How to Overcome Them.

ExSight Ventures Leads First Close Financing Round, alongside InFocus Capital, to Support Pre-clinical Development of Sustained Release Biologic and Small Molecule Therapeutics; Visionary Ventures Leads Second Close Financing

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that the ZOLL AED 3® defibrillator received premarket approval (PMA) by the FDA for use by lay rescuers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005565/en/ ZOLL AED 3 (Photo: Business Wire) “ZOLL